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Regulatory T cells control strain 
specific resistance to Experimental 
Autoimmune Prostatitis
Maria L. Breser1, Andreia C. Lino2, Ruben D. Motrich1, Gloria J. Godoy1, 
Jocelyne Demengeot2,* & Virginia E. Rivero1,*
Susceptibility to autoimmune diseases results from the encounter of a complex and long evolved 
genetic context with a no less complex and changing environment. Major actors in maintaining health 
are regulatory T cells (Treg) that primarily dampen a large subset of autoreactive lymphocytes escaping 
thymic negative selection. Here, we directly asked whether Treg participate in defining susceptibility 
and resistance to Experimental Autoimmune Prostatitis (EAP). We analyzed three common laboratory 
strains of mice presenting with different susceptibility to autoimmune prostatitis upon immunization 
with prostate proteins. The NOD, the C57BL/6 and the BALB/c mice that can be classified along a 
disease score ranging from severe, mild and to undetectable, respectively. Upon mild and transient 
depletion of Treg at the induction phase of EAP, each model showed an increment along this score, most 
remarkably with the BALB/c mice switching from a resistant to a susceptible phenotype. We further 
show that disease associates with the upregulation of CXCR3 expression on effector T cells, a process 
requiring IFNγ. Together with recent advances on environmental factors affecting Treg, these findings 
provide a likely cellular and molecular explanation to the recent rise in autoimmune diseases incidence.
Susceptibility or resistance to autoimmune disorder has a clear genetic component in human and in mouse mod-
els1. However, the multifactorial nature of organ specific autoimmunity has limited our understanding of the 
biology behind the processes that define which organism is affected, and which organ is targeted upon common 
immunoregulation disorder2. Murine models of autoimmune disease relying on immunization with autoantigens 
offer the possibility to focus on a defined tissue target and dissect susceptibility factors others than those involved 
in the original immunological stimuli3,4.
According to the auto-antigen used as immunogene, mouse strains display specific disease susceptibility or 
resistance. For instance alpha-myosin or collagen immunization induces experimental autoimmune cardiomy-
opathy or arthritis, respectively, in BALB/c but not in C57BL/6 mice, while similar immunization with myelin 
oligodendrocyte glycoprotein leads to encephalomyelitis in the latter but not in the former strain5–7. Other models 
of induced autoimmunity rely on immunization with total protein extract of a given organ, multiplying the num-
ber of antigens in a single protocol and thus presumably enlarging the repertoire of effector cells, as is the case for 
experimental autoimmune prostatitis (EAP) where the immunogene is a protein extract of the whole prostate8. 
In these type of models too, the combination of strain and antigen mixture defines the outcome of immunization, 
and EAP is evident in NOD and C57BL/6 but undetected in BALB/c mice9.
The most commonly evoked notion to explain susceptibility/resistance to organ-specific autoimmunity is 
that MHC-antigen complexes are heterogenous in number or affinity among different strains10. Alternatively, 
as selection of the TCR repertoire appears to result in the purging of autoreactivity, this process may be more or 
less efficicient in various strains11. However, in most models of immunization with self-protein, antigen specific 
immune response can be detected whether disease follows or not, indicating that other layers of immune control, 
beyond the engagement of effector cells, condition the evolution to disease12. Intriguingly, the notion that some 
strains are biased toward specific cytokine profiles, e.g. Th1 for C57BL/6 and Th2 for BALB/c mice, hardly explain 
the mirror image presented above, i.e. that the same strain is susceptible to some inflammatory diseases and not to 
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others13. Together, these observations leave open the possibility that specific control, dampening the progression 
of immune responses at the site of immunization to organ infiltration and associated tissue destruction, partipates 
in resisting the pathological process14. Among those, suppression by regulatory T cells (Treg) is a possibility, as 
these cells are now known to exert other functions in addition to their role in preventing effector cell activa-
tion14,15. Null mutation in Foxp3, a transcription factor necessary and required for Treg differentiation and func-
tion16, unleashes a large repertoire of auto-reactive cells that escape negative selection and lead to a multiorgan 
autoimmune disease that is fatal in early age in both mice and humans17. Treg dampen immune responses in a cell 
contact or justacrine manner upon TCR engagement, through their expression of immunosuppresor cytokines 
(TGF-β and IL-10) and check-point molecules (CTLA4)18,19. They were also recently implicated in tissue-healing 
and damage control, notably through the expression of amphiregulin20.
Over the past decade our laboratory developed a mouse model of EAP8,9 that serves to mimick chronic pros-
tatitis/chronic pelvic pain syndrome (CP⁄CPPS), one of the most prevalent diseases in urologic clinics21. CP⁄CPPS 
is an inflammatory disease that affects men younger than 50 years old in the absence of detectable infection22, 
and associates with Th1 like prostate specific reactivities23. Likewise, immunization of young adult males mice 
with prostate proteins together with adjuvants leads to prostatitis8, a progression strictly dependent on INFγ and 
the associated chemokine receptor CXCR39,24. Although all mice strains mount antigen specific responses upon 
immunization, NOD mice develop a severe disease, C57BL/6 animals exhibit moderate prostate infiltration and 
BALB/c mice show no prostate tissue alterations9,25.
We used the EAP model to assess the role of Treg in defining strain specific susceptibility or resistance to 
induced autoimmune disease. By treating mice with anti- CD25Ab to transiently deplete Tregs at the time of EAP 
induction, we reveal that these cells dampen a Th1/Tc1 response and ensuing prostrate infiltration, in all mice, 
including in the resistant BALB/c strain. These findings indicate that beyond genetic factors imposing strain 
intrinsic effector cell repertoire or tissue resilience, resistance to EAP is promoted by a regulatory mechanism that 
dampens a preexisting potential for tissue infiltration and associated destruction. In view of the natural dynamics 
and plasticity of Treg, these findings strengthen the notion that both genetic and environmental factors contribute 
to autoimmune disease susceptibility, the latter more easily explaining the recent rise in disease incidence.
Results
Both EAP susceptible and resistant mice mount an immune response upon prostate antigen 
immunization. To assess whether regulatory T cells naturally limit the induction of EAP in mice we tested 
three mouse strains presenting varying degree of susceptibility or resistance to the disease. We first choose to 
compare NOD, C57BL/6 and BALB/c mice that develop severe, mild and no disease, respectively9,25. Animals 
were submitted to a single injection of the depleting anti-CD25 Ab (PC61), or of the isotype control rat IgG1 
(YCATE), one day before immunization (Fig. 1A). Analysis of Foxp3 expressing cells at steady state confirmed 
that NOD and BALB/c mice present the lowest and highest frequency of regulatory T cells, respectively26,27. 
In all strains Foxp3+ cells expressed similar levels of Foxp3 and GITR and about half of them expressed CD25 
(Supplementary Fig. 1A,B). Consistently with this phenotype, a single injection of PC61 leads to about 50% 
reduction in CD4+ Foxp3+ T cells and remove about 80–90% of CD4+ CD25hi Foxp3+ T cells in all strains of 
mice, as tested 48 h post injection (Fig. 1B, Supplementary Fig. 1C). This depletion is transient, and in absence of 
other interventions normal number of cells is recovered in the following 20 days28,29. Immunization with pros-
tate proteins (PAg) emulsified in CFA was conducted as reported before9 and consisted of a priming injection 
followed by a boost 15 days later. Animals were analyzed at day 24, a time point our previous studies established 
as optimal for EAP evaluation9,24. To assess the amplitude of the immune response we first measured serum Ig 
specific to prostate steroid-binding protein (PSBP, also named prostatein), an abundant immunogenic antigen 
from the prostate30,31. As previously described9, all strains mounted a robust humoral response upon immuni-
zation, with high titers of antigen specific IgG1 and IgG2a/c. In the three strains, treatment with anti-CD25 Ab 
readily increased PSBP specific IgG2a/c titers as indicated by several log2 differences (Fig. 1C). We next monitored 
the extent of overall cellular activation by performing FACS analysis of spleen and lymph nodes draining the 
prostate (Fig. 1D and Supplementary Fig. 1D). Mice were analyzed in steady state conditions or after immuni-
zation and anti-CD25 or control Ab treatment. In all strains, immunization per se readily increased the number 
of CD62LlowCD44high memory/effector T cells recovered when compared to steady state conditions, and prior 
anti-CD25 Ab administration amplified this effect (Fig. 1D). Similarly, the number of CD62LhighCD44high cen-
tral memory T cells recovered upon immunization was increased in mice that were pretreated with anti-CD25 
(Supplementary Fig. 1C). In control as in treated groups, the response was higher in NOD than C57BL/6 mice, 
and BALB/c animals were the less responsive. Strikingly, in all strains, immunization per se readily increased the 
number of CD4+ Foxp3+ cells when compared to steady state conditions (Fig. 1D). This increment was partially 
affected by prior anti-CD25 Ab treatment in NOD and BALB/c mice, but not in B6 animals, suggesting strain 
specific differences in the kinetics of Treg recovery/proliferation (Fig. 1D). Together these results indicate that all 
3 strains do mount an immune response, limited by CD25+ regulatory cells, upon PAg immunization.
CD25+ regulatory cells dampen a Th1/Tc1 immune responses in both EAP susceptible and 
resistant mice. We further assessed the class of the immune response under the control of CD25+ regula-
tory cells in the three strains. Intracellular staining for IFNγ and IL-17 in gated CD3+ T cells from draining LN 
cells collected in the experiments described above revealed that anti-CD25 Ab treatment amplified a Th1/Tc1 
rather than a Th17 response (Fig. 2A). To focus the analysis on antigen specific T cells, draining LN cells were 
maintained in culture in conditions favoring survival and expansion of PSBP specific cells9. Three days later, 
both recovered cells and culture supernatants were analyzed by FACS (Fig. 2B) and ELISA (Fig. 2C), respec-
tively. In agreement with previous work indicating that IFNγ is required for EAP9,24, antigen specific IFNγ +CD3+ 
proportion was increased in NOD when compared to C57BL/6 mice and reduced in BALB/c animals. Indeed, 
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FACS analysis of the cells recovered from the cultures, after intracellular staining for IFNγ and IL-17, showed the 
highest levels of IFNγ +CD3+ in the NOD strain after anti-CD25Ab treatment (Fig. 2B). Analysis of culture super-
natants corroborated the same pattern; anti-CD25 Ab treatment raised the level of antigen specific secretion of 
IFNγ in all strains, with treated BALB/c mice approaching the values obtained in untreated C57BL/6 animals, and 
treated C57BL/6 approaching the values obtained in untreated NOD mice (Fig. 2C). In contrast, the antigen spe-
cific production of IL-17, while also increased upon anti-CD25 Ab treatment, was not strain specific. While the 
frequency of IL10+CD3+ cell did not change, an increased IL-10 secretion (notably in NOD and BALB/c mice) 
was observed in anti-CD25 Ab treated mice, suggesting that other cells than T cells produced IL-10, and these 
are also under Treg control. Surface staining for the chemokine receptors CXCR3 and CCR6 respectively associ-
ated with Th1/Tc1 and Th17/Tc17 classes of response32, confirmed a Th1/Tc1 strain-specific pattern (Fig. 2D,E). 
Antigen specific CXCR3 T cells were more abundant in NOD than C57BL/6 mice, and less prevalent in BALB/c 
animals, while CCR6 expression was not correlated to EAP susceptibility. As for IFNγ , CXCR3 analysis indi-
cated that treatment with anti-CD25 Ab promoted a C57BL/6-like response in BALB/c animals and a NOD-like 
response in C57BL/6 mice (Fig. 2D,E).
CD25+ regulatory cells prevent Prostatitis in susceptible and resistant mice. Prostatitis is clearly 
evidenced by immunohistochemistry on prostate tissue to reveal CD45+ leucocytes infiltration and to evaluate 
tissue damage (Fig. 3A,B). Immunized control mice confirmed the high prevalence and severity of EAP in NOD 
Figure 1. CD25+ cell depletion enhances immune responses in all strains. (A) Experimental scheme 
representing the protocol of treatment and immunization: i.v. injection with anti-CD25Ab or control Ab on 
day − 1, i.d. immunization with PAg plus adjuvant on days 0 and 15, and mice sacrifice on day 24. This protocol 
was applied to six to 8 week old male NOD, C57BL/6 and BALB/c mice. (B) Foxp3+ CD4+ and CD25+ Foxp3+ 
CD4+ T cell depletion efficiency tested 48 h after anti-CD25 Ab treatment measured by Flow cytometry. 
(C) PSBP-specific IgG1 and IgG2a-c levels measured in serum samples on day 24 by ELISA as described in 
Materials and Methods. (D) Gating strategy used to evaluate absolute numbers of effector (CD62LlowCD44hi) T 
cells and Treg (CD4+ Foxp3+) cells in draining LN from individual NOD, C57BL/6 and BALB/c mice in steady 
state conditions (without treatment) or on day 24 of the experimental protocol. Data are shown as mean ± SEM, 
n = 6 mice per group and representative of two independent experiments. The p values were obtained using 
one-way ANOVA followed by Bonferroni post-hoc analysis.
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mice, the milder manifestation in C57BL/6 animals and the absence of infiltrates in BALB/c mice. Treatment with 
anti-CD25 Ab at the induction phase enhanced tissue cell infiltration and destruction in both susceptible strains. 
Strikingly, the treatment promoted disease in the otherwise resistant BALB/c mice, with an incidence of 5 out of 
6 tested animals, and a severity comparable to that of control C57BL/6 animals (Fig. 3B). Significant histological 
alterations were detected in prostate tissue from anti-CD25 Ab treated NOD mice consisting in diffuse perivascu-
lar and stromal mononuclear cell infiltration accompanied by edema and severe tissue disorganization. Prostate 
Figure 2. CD25+ cell depletion diverts specific immune response towards a Th1/Tc1 pattern. Mice were 
treated as in Fig. 1, pooled draining LN from individual NOD, C57BL/6 and BALB/c mice were analyzed at day 
24, either straight (A) or after stimulation with PSBP for 72 h (B–E). (A) Flow cytometric analysis for IFNγ and 
IL-17A intracellular expression in CD3+ cells isolated from draining LN following in vitro stimulation with 
PMA/inomycin for 5 h in the presence of Golgi Stop. (B) Percentage of IFNγ + CD3+, IL-17A+ CD3+ and IL-10+ 
CD3+ T lymphocytes isolated from draining LN following in vitro stimulation with PSBP for 72 h and then 5 h. 
PMA/ionomycin incubation in the presence of Golgi Stop as described in Materials and Methods. (C) Culture 
supernatants of mononuclear cells from draining LN isolated on day 24 of the experimental protocol, analyzed 
by ELISA. (D) Representative flow cytometry dot plots of gating strategy and CXCR3 and CCR6 staining on the 
gated CD3+ T cell population after 72 h of PSBP stimulation. (E) Percentages of CXCR3+ and CCR6+ in CD3+ 
T cells after 72 h of PSBP stimulation. Data are shown as mean ± SEM, n = 6 per group, and are representative of 
two independent experiments. The p values were obtained using one-way ANOVA followed by Bonferroni post-
hoc analysis; ns, non significant.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:33097 | DOI: 10.1038/srep33097
Figure 3. CD25 cell depletion promotes Experimental Autoimmune Prostatitis. NOD, C57BL/6 and 
BALB/c mice were treated as in Fig. 1. (A) Representative immunohistochemistry assays for CD45+ cells in 
prostate tissue sections from NOD, C57BL/6 and BALB/c mice analyzed at day 24. Arrows indicate the CD45+ 
cell clusters infiltrating the prostate gland. Original magnification X200. (B) Incidence and prostate histological 
scores from mice under study. (C) Presence of leukocytes infiltrating the prostate gland from animals under 
study, representative dot plots CD45+ versus CD3+ cells. (D) Bar graphs shown absolute numbers of CD45+ and 
CD3+ cells infiltrating the prostate gland from animals under study. (E) Percentages of CD3+, CD19+, CD11b+ 
and others in the prostate infiltrate from animals under study. (F) Absolute number of CXCR3+ CD45+ and 
CCR6+ CD45+ cells infiltrating the prostate gland from mice under study. Data are shown as mean ± SEM, 
n = 6 mice per group, and are representative of two independent experiments. The p values were obtained using 
one-way ANOVA followed by Bonferroni post-hoc analysis; ns, non significant.
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samples from anti- CD25 Ab treated C57BL/6 mice exhibited multifocal perivascular and stromal mononuclear 
cell infiltration. Finally, significant histological alterations were detected in prostate tissue from anti-CD25Ab 
treated BALB/c mice, consisting in focal perivascular and stromal mononuclear cell infiltration, accompanied by 
edema (Fig. 3A).
We next quantified and characterized prostate infiltrating leukocytes by performing FACS analysis (Fig. 3C–F 
and Supplementary Fig. 2A). In a remarkable concordance with the histological scores, the number of leucocytes 
(CD45+) or T cells (CD3+) recovered from prostate tissues were more elevated in NOD mice than in C57BL/6 
animals (about 2 folds), and BALB/c presented with the lowest values. For these parameters too, administration 
of anti-CD25 Ab at the induction phase of EAP increased the values, such that treated BALB/c mice resembled 
control C57BL/6 animals and treated C57BL/6 mice resembled untreated NOD animals. When analyzing the 
leukocyte populations composing the infiltrate, CD3+ and CD11b+ cells were the most abundant while the fre-
quency of CD19+ cells was low. These proportions were similar irrespective of anti-CD25 Ab treatment, with the 
exception of untreated healthy BALB/c mice which as expected exhibited lower frequency of CD3+ cells within 
the infiltrates (Fig. 3E). Inside the CD3+ cellular subset about 60% were CD4+ and 40% were CD8+ T cells, irre-
spectively of the strain or the treatments (Supplementary Fig. 2A). In agreement with a major role for CXCR3 in 
promoting T cell migration from the lymph nodes to the tissue, the number of infiltrating T cells expressing this 
chemokine receptor positively correlated with disease severity (Fig. 3F). Contrarily to our analysis of the draining 
lymph nodes (Fig. 2D), the frequencies of T cells expressing CXCR3 in the infiltrates were constant across the 
different experimental groups (Supplemental Fig. 2B). These results support the notion that CXCR3 expression is 
acquired in the lymph nodes and facilitates migration to the tissue. Finally, little or no CCR6+ cells were detected 
in prostate infiltrates (Fig. 3F, Supplementary Fig. 2B). Together, these results indicate that CD25+ regulatory 
cells dampen a tissue specific Th1/Tc1 deleterious autoimmune response, triggered by immunization, in both 
EAP susceptible and resistant strains. In turn, this finding indicates that EAP resistance in BALB/c mice is not 
solely the result of efficient negative selection of the TCR autoimmune repertoire, or of poor antigen presentation.
CD25+regulatory cells dampen CXCR3 expression on effector T cells, a process requiring 
IFNγ. In a previous work, we evidenced that IFNγ is required for EAP occurrence through its essential role 
in the induction of CXCR3 expression by T cells, a mechanism of trans-regulation9. As anti-CD25 Ab treatment 
promoted both IFNγ and CXCR3 expression upon immunization, we next asked whether CD25+ regulatory T 
cells affected CXCR3 expression independently of their role in dampening cytokine production. We analyzed 
NOD-IFNγ −/− mice that are fully resistant to EAP9. These mice mount a Th17/Tc17 type of response upon immu-
nization as indicated by the presence of IL-17 producing and CCR6 expressing T cells in pooled draining LN at 
day 24 (Fig. 4A,B). Both T cell phenotypes were amplified by anti-CD25 Ab administration before immunization, 
while CXCR3 expression remained undetectable (Fig. 4A,B). In addition, NOD-IFNγ −/− treated with anti-CD25 
Ab remained resistant to EAP showing no infiltration or damage in the prostate gland (Fig. 4C). To allow for 
CXCR3 expression, we complemented the IFNγ deficiency by providing recombinant-IFNγ (rIFNγ ) through 
repeated injection during the boosting phase of the immunization9 (Fig. 4D). This treatment per se promotes 
CXCR3 expression and increases the frequency of CXCR3+ cells in draining LN9. In the control conditions (vehi-
cle only), and as observed above, anti-CD25 Ab treatment increased the frequency of cells expressing CCR6. In 
contrast, in presence of rIFNγ , anti-CD25 Ab treatment increased by twofold the frequency of antigen specific 
CXCR3+ cells, an increment associated with a twofold reduction in the frequency of CCR6+ cells (Fig. 4E). This 
switch in the class of chemokine receptors expressed by T cells upon immunization, and its amplification by the 
depletion of CD25+ regulatory T cells, resulted in prostate infiltrations with evident tissue destruction (Fig. 4F), 
to an extent similar to that observed in WT animals (see Fig. 3A), and with a disease score close to 3. In the same 
animals, cellular analysis of prostate infiltrates revealed increased number of leucocytes and T cells (Fig. 4H), 
reaching numbers similar to those observed in WT mice (see Fig. 3D). From these data, we conclude that CD25+ 
regulatory cells dampen the differentiation of CXCR3+ cells, by a process independent of effector T cell autocrine 
IFNγ secretion.
Discussion
By performing limited and transient Treg depletion at the time of EAP induction in susceptible and resistant mice 
we reveal that, beyond strain specific repertoire or tissue resilience, a layer of immune control dampens patholog-
ical responses, to the point of conferring disease resistance to BALB/c mice. This approach applied to mutant mice 
also provided key information regarding the role of specific inflammatory cytokines and chemokine receptors in 
EAP onset. Together, this work provides new clues to our understanding of susceptibility to autoimmune disease 
and its variation in complex genetic and environmental settings, as it is the case for humans.
To assess the role of Treg in defining the susceptibility and severity to EAP we choose a loss of function 
approach and resorted to anti− CD25 antibody mediated cellular depletion. The CD25 molecule is expressed by 
most Foxp3+ regulatory T cells, especially those functionally engaged in regulation33. It is also expressed by acti-
vated T cells, albeit transiently, a small subset of B cells, and few dendritic cells34,35. While Ab mediated depletion 
may lack in specificity when compared to targeted genetic engineering, it offers the unique opportunity to test 
various genetic background in a short time. Moreover, available genetic models were not directly adapted to serve 
our objectives. Mice bearing a null mutation in the Foxp3 gene are fully deficient in Treg and develop spontane-
ously a severe and multi-organ pathology leading to early death36, a model not easily amenable for strain specific 
analysis and not adapted for the case of prostatitis as death occurs before full development of the prostate (unpub-
lished observation). Animals bearing the diphtheria toxin receptor gene under the transcriptional control of 
Foxp3 allow for Treg depletion in adults, however discrepancy of results across the available models37,38 still await 
disambiguation before engaging in organ and strain specific analyses. Moreover, diphtheria toxin has side effects 
in mice, and more specifically, its toxicity is increased when combined with adjuvants like CFA39. Administration 
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Figure 4. CD25+ cell depletion enhances IFNγ dependent CXCR3 T cell expression and thus autoimmune 
prostatitis in NOD-IFNγ −/− mice. Six weeks old NOD-IFNγ −/− mice were treated as in Fig. 1A and their 
draining LN cells and prostate infiltrates were analyzed at day 24. Draining LN cells from individual mice were 
stimulated with PSBP for 72 h. (A) Percentages of IL-17A+ cells in gated CD3+ lymphocytes in draining LN. 
(B) Representative dot plot analysis of CXCR3 and CCR6 staining in gated CD3+ T cell from draining LN. (C) 
Representative dot plot analysis and bar graphs showing absolute numbers of CD45+ and CD3+ cells infiltrating 
the prostate gland from NOD-IFNγ −/− mice analyzed at day 24. (D) Experimental scheme representing the 
protocol of anti-CD25 Ab treatment, immunization, i.p. treatment with rIFNγ on day 16, 18, 20 and 22 and 
mice sacrifice on day 24. (E) Representative flow cytometry dot plots of CXCR3 and CCR6 staining in gated 
CD3+ T cell population from draining LN. (F) Representative immunohistochemistry assay for CD45+ cells in 
prostate tissue sections from control or anti-CD25 treated NOD-IFNγ −/− mice injected with vehicle or rIFNγ .  
(G) Presence of leukocytes infiltrating the prostate gland from anti-CD25 treated NOD-IFNγ −/− mice treated 
with rIFNγ or vehicle evaluated by flow cytometry. Bars show absolute numbers of CD45+ and CD3+ cells 
infiltrating the prostate gland from animals under study. (H) Percentages of CXCR3+ CD3+ and CCR6+ CD3+ 
T cells infiltrating in the prostate gland from NOD-IFNγ −/− mice under study. Data are shown as mean ± SEM, 
n = 4 mice per group, and are representative of three independent experiments. The p values were obtained 
using one-way ANOVA followed by Bonferroni post-hoc analysis.
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of a single dose of the monoclonal anti-CD25 Ab PC61 in mice, induces a depletion of CD25 expressing cells that 
is transient, due to Ab clearance and homeostatic rebound28, and cannot be prolonged due to the Ab intrinsic 
immunity in mice (unpublished observations). In addition to cellular depletion, PC61 may functionally inactivate 
the remaining Treg through antibody-mediated blockade of IL-2 signaling40,41. However, depletion and functional 
inactivation remain moderate as no manifestation of systemic or tissue specific autoimmunity has ever been 
reported or noted42 (and unpublished observation) upon a single injection of PC61.
We found that a reduction in regulatory cell number during the priming phase of EAP was enough to break 
down self-tolerance in the resistant BALB/c strain and worsen disease severity in both the mildly and the highly 
susceptible C57BL/6  and NOD mice, respectively. A role for Treg in preventing spontaneous prostatitis occur-
rence in susceptible mice has been evidenced earlier. Neonatal thymectomy in mice results in spontaneous auto-
immunity targeting varying organs, including the prostate43. Several line of evidences indicate that disease in this 
system results from alteration in Treg repertoire and function, and specifically, adoptive transfer shortly after 
day 3 thymectomy of Treg isolated from healthy donor prevents EAP44. In our system, effector and potentially 
pathogenic cells are primed and boosted by the immunization, and transient Treg depletion evidence that nega-
tive selection does not explain disease resistance in BALB/c mice. As acknowledged above anti CD25 Ab targets 
other cells than Treg. In a model of induced Autoimmune Experimental Uveitis, C57BL/6 mice treated with anti 
CD25 Ab showed decreased numbers of Treg but also γ δ T cells and CD11c+ CD3−CD25+ dendritic cells that 
could explain the observed reduced Th17 and enhanced autoreactive Th1 response35. In our study we did not dis-
criminate the relative contribution of Treg and other CD25 expressing cells in defining EAP susceptibility.While 
additional layers of regulation may well take place, our results establish that susceptibility and resistance to EAP 
is defined by dominant regulatory mechanisms and not merely by recessive tolerance.
Previous studies have reported that Treg depletion may converts specific strains from a non-responder to 
a responder phenotype in infectious setting (e.g. ref. 45). In setting of autoimmunity, most studies used Treg 
depletion to evidence their protective role in animals prone to spontaneously develop disease. This is the case 
of a recent work revealing that transient Treg depletion induced by administration of a low dose and very short 
regimen of diphtheria toxin in Foxp3-DTR mice induces disease in BALB/c CrSlc, a substrain well know for its 
susceptibility to gastritis46. In our experimental setting of induced autoimmunity, immunization provides for 
normalization of the priming event, across strains. With this approach, the role of regulatory cells in susceptibility 
or resistance to disease can be addressed beyond questioning, or eluding, the still obscure issue of the original 
tissue-antigen specific priming of pathogenic cells.
Despite Treg depletion prior to immunization, BALB/c mice developed a moderate immune response and a 
mild disease, comparable to those occurring in untreated C57BL/6 animals. As previously reported, we found 
higher frequencies of CD4+ Foxp3+ cells in peripheral lymphoid organs of BALB/c mice when compared with 
NOD and C57BL/6 animals, in steady state conditions26,27. Moreover, BALB/c when compared to C57BL/6 Treg 
were shown to be more efficient at suppressing conventional cell26, a result not reproduced later27. It is conceiv-
able that our partial depletion preserved antigen specific Treg in BALB/c more than in C57BL/6 mice, due to 
natural enrichment or higher efficiency in the former strain. Alternatively, BALB/c mice could carry less antigen 
specific conventional cells. The two notions seems actually related, as indicated by recent works confirming that 
the repertoire of self-reactive conventional and regulatory T cells is sorted according to specific properties of the 
interactions between the TCR and MHC-self-peptide in the thymus47–49, and it is easily conceivable that these 
properties are tuned by specific MHC alleles.
Our results evidence that in all strains disease severity associates with enhanced generation of antigen spe-
cific T cells expressing CXCR3, but not CCR6. In a previous work we showed that IFN-γ is required for EAP 
occurrence due to its specific role in promoting effector T cells migration to the prostate tissues9. This study also 
revealed that IFNγ acts in trans to upregulate CXCR3 and downregulate CCR6 chemokine receptors on effector 
T cells. In turn, this work indicated that irrespectively of whether effectors cells are IFNγ or IL-17 producers, it 
is their chemokine receptor expression pattern that determines their capacity to infiltrate the tissues. Here, in 
the three mouse strains under study, we show that a transient depletion of Treg cells at the inductive phase of the 
disease promotes a Th1/Tc1 response, with moderate effect on the Th17/Tc17 subset. In contrast, in mice deficient 
for IFNγ , the same treatment enhanced a robust Th17 response, although not associated with EAP. These results 
are consistent with the widely accepted notion that Treg inhibit a large range of immune cells, including Th1, 
Th17, Th2 and also CD8+ T cells. In our system, the context is imposed by CFA that provides the signal neces-
sary to define the class of responses. In turn, our results support the notion that in wild type animals and under 
inflammation promoted by CFA, Treg dampen the dominant IFNγ responses even in the Th2 biased BALB/c 
background.
Th1 and Th17 pathogenic effectors cells once induced in the periphery must traffic to their target organs and 
this traffic is associated with the expression of specific chemokine receptors and also with the induction of appro-
priate chemokines in the target organ50. More relevant to the mechanism of autoimmune disease, our results also 
support the notion that the pathology results from the upregulation of CXCR3 on effector cells, rather than on 
specific cytokine profiles. This is best illustrated in our analysis of IFNγ deficient mice, where although effector 
cell numbers are increased through transient Treg depletion, these are pathologic only if exposed to IFNγ . In turn 
these results indicate that BALB/c mice are resistant to EAP, not because of a lack of potential to mount an antigen 
specific response, but owing to the inhibition of Th1/Tc1 response by Treg, that prevent the production of IFNγ 
required for effector cells migration to the prostate.
Choosing three strains to cover a spectrum of susceptibility, from the NOD with exacerbated disease, the 
C57BL/6 with mild inflammation and to the resistant BALB/c mice, we show that transient Treg depletion moves 
each strain to the next degree of severity: the severity of prostate infiltration in treated BALB/c animal is similar 
to that of untreated C57BL/6 and likewise treated C57BL/6 animals appear as affected as untreated NOD mice 
(Fig. 3). This finding is striking as it indicates that mild disturbances in the Treg pool can confer susceptibility 
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to a resistant strain, offering in turn a likely explanation to the recent rise in autoimmune disease incidence in 
developed countries51. This increment was too rapid to result from enrichment of the gene pool with susceptibil-
ity alleles. Along the hygiene hypothesis, societal factors such as systematic vaccination reduced the occurrence 
of repeated immune activation that otherwise follow pediatric infections, and in turn, altered intrinsic features 
of the immune system. Evidences that Treg differentiation, survival and expansion depend on IL-2 produced by 
effector cells28,52, together with their ability to directly respond to TLR ligands53, and therefore bacterial, viral and 
extra-cellular matrix component, provided a cellular and molecular basis to the hygiene hypothesis. This theory 
predicts overall lower number or decreased robustness of Treg in “cleaner environment”, a situation somewhat 
mimicked by transient and mild depletion of Treg as we performed here. In keeping with environmental and 
life-style changes, recent findings indicate that beneficial components of our microbiota promote Treg expansion 
and differentiation54, and the now routine practices of administrating frequent boost of antibiotics may have 
increased our susceptibility to autoimmunity.
Material and Methods
Mice and Antigens. Mouse strains used in this study were NOD/LtJ (NOD/ShiLtJ), C57BL/6 and BALB/c 
purchased from The Jackson Laboratory (Bar Harbor, ME). NOD-IFNγ −/− (NOD.129S7(B6)-IFN-γ tm1Ts) mice 
were kindly provided by Dr. Diane Mathis and Christophe Benoist (The Jackson Laboratory). All animals were 
housed and maintained under SPF conditionsin the Animal Facilities of the Facultad de Ciencias Químicas, 
Universidad Nacional de Córdoba or the Instituto Gulbenkian de Ciência, and used at the age of 6–8 wk. All ani-
mal experiments were approved by and conducted in accordance with guidelines of the Committee for Animal 
Care and Use of the Facultad de Ciencias Químicas, Universidad Nacional de Córdoba and the ethics committee 
of the Instituto Gulbenkian de Ciência in strict accordance with the recommendation of the Guide to the Care 
and Use of Experimental Animals published by the Canadian Council on Animal Care (OLAW Assurance num-
ber A5802-01) and the Portuguese State Veterinary division (DGV).
The preparation of a mixture of prostate antigens (PAg) and the purification of Prostatein, or prostate 
steroid-binding protein (PSBP), were performed as previously described55. The purity of the PSBP preparation 
was > 95% as evaluated by Western blot and was LPS-free as tested by Gel clot 0.03 endotoxin units/ml sensitivity 
(Charles River, Laboratories International, Wilmington, NY, USA).
Antibodies. Commercially available antibodies used in different experiments performed and their respec-
tive manufacturer were as follows: anti-CD4 (RM4-5), anti-CD11b (M1/70), anti-CD3 (145-2C11), anti-GR1 
(RB6-8C5); anti-CD44 (IM7), anti-CD62L (MEL-14), anti-IFNγ (XMG1.2), anti-IL-17A (TC11-18H10), and IgG 
isotype controls were purchased from BD Biosciences (San Diego, CA, USA). Anti-CD45 (30-F11), Anti-CD8a 
(53–6.7), anti-IL-10 (JES5-16E3), anti-IL-17A (eBIO17B7), anti-CD25 (PC61 and 7D4); anti-Foxp3 (FJK-16s) 
and Foxp3 Staining Buffer were purchased from eBioscience (San Diego, CA, USA). Anti-CD45 (30-F11), 
anti-CD11b (M1/70), anti-CCR6 (29-2L17), anti-CXCR3 (CXCR3-173), anti-CCR4 (2G12) and anti-CCR5 
(HM-CCR5) were purchased from BioLegend (San Diego, CA, USA).
EAP induction and histological prostatitis score. Six- to 8-week-old male NOD, C57BL/6, BALB/c or 
NOD-IFNγ −/− mice were subcutaneously immunized in the hind footpad and in the base of the tail with PAg 
(300 μ g/mouse) or saline solution emulsified in CFA (Sigma-Aldrich, St. Louis, MO, USA) in a total volume of 
150 μ l/mouse. Mice received immunizations at days 0 and 15, and then were sacrificed at day 24 of the experi-
mental schedule9,24. The severity of EAP was assessed by determining the histological score, which was analyzed 
in a double-blind manner and computed for individual glands by summing the pathologic grade of each prostate 
tissue section and dividing by the total number of sections examined. The degree of inflammation was assessed 
using a score of 0 to 4:0, no inflammation; 1, mild but definite perivascular cuffing with mononuclear cells; 2, 
moderate perivascular cuffing with mononuclear cells; 3, marked perivascular cuffing, hemorrhage with some 
parenchymal inflammatory cells; 4, marked perivascular cuffing, hemorrhage and numerous mononuclear and 
mast cells in the parenchyma, in 5-mm-thick prostate tissue sections of each organ per animal that were pro-
cessed by conventional hematoxylin and eosin staining. Slides were visualized in a microscope Nikon TE 2000U 
(Nikon, Osaka, Japan).
In vivo CD25+ cell depletion. NOD, C57BL/6, BALB/c and NOD-IFNγ −/− mice were injected intrave-
nously (i.v.) with 500 μ g of anti-CD25Ab (clone PC61). Control mice received the same amount of rat IgG Ab 
(clone YCATE) produced at the Instituto Gulbenkian of Ciência. Depletion was evaluated using anti-CD25 Ab 
(clone 7D4) and Foxp3 staining. Mice from all strains received anti-CD25 or IgG control Ab 1 day before starting 
the EAP immunization schedule as previously described28.
In vivo treatment with recombinant IFNγ. NOD–IFNγ −/− were immunized to induce EAP and then 
received intraperitoneal (i.p.) injections with 104 U/day/mouse of rIFNγ (Peprotech, D.F., Mexico) resuspended 
in 100 μ L of 0.1% BSA/PBS. Recombinant IFNγ was administrated on days 16, 18, 20, and 22 of the EAP experi-
mental schedule. In some experiments, mice were injected with anti-CD25 or IgG control Ab on the day − 1, then 
started the immunization protocol and were treated with rIFNγ on days 16, 18, 20 and 22 of the EAP experimen-
tal schedule.
Prostate antigen specific antibodies in serum. Prostate steroid-binding protein–specific IgG1, IgG2a-c 
serum levels were titrated by conventional ELISA using specific detection antibodies in multiwell plates (Corning, 
Costar, Cambridge, MA). Plates were precoated with 100 μ L per well of PSBP (20 mg/mL) in 0.05 M carbonate 
buffer of pH9.6. After overnight incubation at 4 °C, microwells were washed twice and blocked with 3% BSA 
(Sigma-Aldrich) in PBS for 2 hours at 37 °C, rinsed with PBS-Tween 20 at 0.05%, and then filled with 100 μ L of 
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serum (obtained after cardiac puncture) serial dilutions (starting at 1/50) for 1 hour at 37 °C. To detect specific 
IgG1, IgG2a-c plates were again washed and incubated with HRP conjugated rat anti-mouse IgG1 or anti-mouse 
IgG2a-c (BD Biosciences) for 1 hour at 37 °C. Plates were thoroughly washed, and the reaction was developed with 
BD OptEIA TMB Substrate Reagent Set (BD Biosciences). Absorbance was measured at 450 nm in a microplate 
reader (Bio-Rad Laboratories, Hercules, CA). Serum reactivity was expressed in titer inversed values.
Cell culture. Single mononuclear cell suspensions were prepared in HBSS (Sigma-Aldrich) from spleen and 
pooled draining lymph nodes of individual mice by Ficoll-Paque PREMIUM 1.084 (GE Healthcare Bio-Sciences 
AB, Uppsala, Sweden) centrifugation gradients. Live cells were counted by Trypan blue exclusion, resuspended in 
RPMI 1640-GlutaMAX medium (Life Technologies, Carlsbad, CA, USA) supplemented with 1% penicillin/strep-
tomycin (Life Technologies), 50 mM 2-ME (Life Technologies), and 10% FCS (Life Technologies), and cultured 
in the presence of PSBP (20 μ g/ml) or medium alone. Plates were incubated at 37 °C in a water-saturated 5% CO2 
atmosphere for 72 hours. After that, cells were processed for surface or/and intracellular cytokine staining and 
analyzed by FACS. Supernatants were frozen at − 80 °C for cytokine quantifications.
Cytokine quantification. Cytokine secretion of cell suspensions was assessed after antigen stimulation at 
a cell density of 1.5 × 106 cell/ml. Cell suspension from spleen or prostate draining lymph nodes were stimulated 
during 72 h with PSBP (20 μ g/ml). IFNγ , IL-17A and IL-10 concentrations in culture supernatants were measured 
by ELISA using paired Abs or specific kits (eBiosciences for IL-17A, and BD Biosciences for IFN-γ and IL-10) 
according to standard protocols and following manufacturer’s instructions.
Flow cytometry. Freshly isolated mononuclear cells from spleen or LN were stained for surface markers 
and intracellular cytokines as previously described9,24. To determine the expression of chemokine receptors, cells 
were stimulated in vitro with PSBP and then staining was performed. In other experiments, after in vitro stim-
ulation with PSBP (20 μ g/ml) for 72 h, cells were incubated for 5 h. with 50 nM PMA and 0.5 μ g/ml ionomycin 
(Sigma-Aldrich) in the presence of Golgi Stop (BD Biosciences). Cell-surface staining of different molecules 
and chemokines receptors was performed followed by intracellular staining of different cytokines using the BD 
CytoFix/Cyto Perm and Perm/Wash kit (BD Biosciences) according to the manufacturer’s instructions. Cells were 
incubated with APC-labeled antibodies to IL-17A (eBiosciences), or CCR6 (BioLegend), and with PE-labeled 
antibodies to IFNγ (BD Biosciences) or CXCR3 (BioLegend). Cells were acquired on FACS Canto II or FACS 
Calibur flow cytometer (BD Bioscience) and analyzed using FlowJo software (Tree Star, Ashland, OR, USA).
Analysis of prostate infiltrating leucocytes. Prostate infiltrating leucocytes analysis was performed as 
previously described9,24. Freshly harvested prostate tissue samples were mechanically disrupted and enzymatically 
digested in RPMI 1640 medium containing 1 mg/ml collagenase D (Roche, Basilea, Switzerland) and DNase 
I (Sigma-Aldrich) for 45 min at 37 °C. After digestion, suspensions were filtered through 75- and 40-μ m cell 
strainers (BD Biosciences) and single-cell suspensions were washed twice in 10% FBS, 2 mM EDTA, and 50 mM 
2-ME supplemented RPMI 1640 medium. Live lymphocyte counts were deduced from the acquisition of a fixed 
number of 10-μ m latex beads (Beckman Coulter, Brea, CA, USA) mixed with a known volume of unstained cell 
suspension in propidium iodide (BD Biosciences). Analyses were performed allowing the exclusion of dead cells 
(propidium iodide positive) inside the indicated gates. After that, cells were stained with different antibodies for 
flow cytometry analysis. Cells were acquired using a FACS Canto II or FACS Calibur (BD Bioscience), and data 
were analyzed using FlowJo software (Tree Star, Ashland, OR).
Immunohistochemistry assays. Formalin-fixed and paraffin-embedded prostate sections were dewaxed 
in xylene, rehydrated, treated with Target Retrieval Solution (Dako Cytomation, Glostrup, Denmark) at 95 °C for 
30 min, and blocked with FC blocking solution (BD Bioscience). Endogenous peroxidase activity was blocked 
with blocking buffer (Dako Cytomation). Then slides were incubated overnight at 4 °C in blocking buffer contain-
ing rabbit anti-CD45 (clone 30-F11) Ab. Slides were washed four times in 10 mM PBS, 0.1% Tween 20, and incu-
bated with anti-rabbit HRP (BD Bioscience) secondary Abs for 2 h at room temperature. Colorimetric detection 
was performed by using Detection Kit (BD Bioscience) and counter stained with hematoxylin.
Statistics. Statistical analysis was performed using one-way or two-way ANOVA with Bonferroni post hoc 
test analysis. Mean ± SEM are represented in the graphs. Statistical tests were performed using the Graph Pad 
Prism 5.0 software. The p value *p < 0.05 was considered significant in all analyses.
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